Neuropeptide FF inhibition of morphine effects in the rat hippocampus

Brain Research

Volumn 750, Issue 1-2, 1997, Pages 81-86

  Miller, Karen K ^a   Lupica, Carl R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

aminobutyric acid; antiopioid; electrophysiology; interneuron; morphine modulating peptide; opioid

Indexed keywords

4 AMINOBUTYRIC ACID; MORPHINE; NALOXONE; NEUROPEPTIDE FF; OPIATE; PD 135158;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; MICROELECTRODES; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0031044270     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01333-9     Document Type: Article

References (40)

1. Allard, M., Geoffre, S., Legendre, P., Vincent, J.D. and Simonnet, G., Characterization of rat spinal cord receptors to FLFQPQR-Famide, a mammalian morphine modulating peptide: a binding study, Brain Res., 500 (1989) 169-176.
2. Allard, M., Theodosis, D.T., Rousselot, P., Lombard, M.C. and Simmonet, G., Characterization and localization of a putative morphine modulating peptide, FLFQPQRFamide, in the rat spinal cord: biochemical and immunocytochemical studies, Neuroscience, 40 (1991) 81-92.
3. Allard, M., Zajac, J.M. and Simonnet, G., Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine modulating peptide, in rat central nervous system, Neuroscience, 49 (1992) 101-116.
4. Devillers, J.-P., Labrouche, S., Castes, E. and Simonnet, G., Release of Neuropeptide FF, and antiopioid peptide, in rat spinal cord slices is voltage and Ca+2 sensitive: possible involvement of P-type Ca+2 channels, J. Neurochem., 64 (1995) 1567-1575.
5. Devillers, J.-P., Mazarguil, H., Allard, M., Dickenson, A.M., Zajac, J.M. and Simonnet, G., Characterization of a potent agonist for NPFF receptors: binding study on rat spinal cord membranes, Neuropharmacology, 33 (1994) 661-669.
6. Devine, D.P., Leone, P., Pocock, D. and Wise, R.A., Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies, J. Pharmacol. Exp. Ther., 266 (1993) 1236-1246.
7. Dunwiddie, T.V., Mueller, A.L., Palmer, M.R., Stewart, J.M. and Hoffer, B.J., Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus I. Effects on pyramidal cell activity, Brain Res., 184 (1980) 311-330.
8. Paris, P., Komisaruk, B., Watkins, L. and Mayer, D.J., Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia, Science, 219 (1983) 310-312.
9. Gouarderes, C., Jhamandas, K., Sutak, M. and Zajac, J.M., Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues, Br. J. Pharmacol., 117 (1996) 493-501.
10. Gouarderes, C., Sutak, M., Zajac, J.M. and Jhamandas, K., Antinociceptive effects of intrathecally administered FSFamide and FMR-Famide in the rat, Eur. J. Pharmacol., 237 (1993) 73-81.
11. Guzman, A., Legendre, P., Allard, M., Geoffre, S., Vincent, J.D. and Simonnet, G., Electrophysiological effects of FLFQPQRF amide, an endogenous brain morphine modulating peptide, on cultured mouse spinal cord neurons, Neuropeptide, 14 (1989) 253-261.
12. Kavaliers, M., Calcium channel blockers inhibit the antagonistic effects of FMRFamide on morphine and stress induced analgesia in mice, Brain Res., 415 (1987) 380-384.
13. Kavaliers, M., Inhibitory influences of mammalian FMRFamide related peptides on nociception and morphine and stress induced analgesia in mice, Neurosci. Lett., 115 (1990) 307-312.
14. 2-related peptides augments morphineand stress-induced analgesia in mice, Peptides, 10 (1989) 741-745.
15. Lake, J.R., Hebert, K.M., Payza, K., Deshotel, K.D., Hausam, D.D., Witherspoon, W.E., Arcangeli, K.R. and Malin, D.H., Analog of neuropeptide FF attenuates morphine tolerance, Neurosci. Lett., 146 (1992) 203-206.
16. Lupica, C.R., δ and μ, enkephalins inhibit spontaneous GABA-mediated IPSCs via a cyclic AMP-independent mechanism in the rat hippocampus, J. Neurosci., 15 (1995) 737-749.
17. Lupica, C.R., Proctor, W.R. and Dunwiddie, T.V., Dissociation of μ, and δ opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro, Brain Res., 593 (1992) 226-238.
18. Madison, D.V. and Nicoll, R.A., Enkephalin hyperpolarizes interneurones in the rat hippocampus, J. Physiol., 398 (1988) 123-130.
19. Magnuson, D.S., Sullivan, A.F., Simonnet, G., Roques, B.P. and Dickenson, A.H., Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord, Neuropeptide, 16 (1990) 213-218.
20. Majane, E.A., Panula, P. and Yang, H.-Y., Rat brain regional distribution and spinal cord neuronal pathway of FLFQPQRF-NH2, a mammalian FMRF-NH2 like peptide, Brain Res., 494 (1989) 1-12.
21. Malin, D.H., Lake, J.R., Arcangeli, K.R., Deshotel, K.D., Hausam, D.D., Witherspoon, W.E., Carter, V.A., Yang, H.-Y., Pal, B. and Burgess, K., Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome, Life Sci., 53 (1993) 261-266.
22. Malin, D.H., Lake, J.R., Fowler, D.E., Hammond, M.V., Brown, S.L., Leyva, J.E., Prasco, P.E. and Doughtery, T.M., FMRF-NH2 like mammaliam peptide precipitates opiate withdrawal syndrome in the rat, Peptides, 11 (1990) 277-280.
23. Malin, D.H., Lake, J.R., Hammond, M.V., Fowler, D.E., Rogillio, R.B., Brown, S.L., Sims, J.L., Leecraft, B.M. and Yang, H.-Y., FMRF-NH2 like mammalian octapeptide: possible role in opiate dependence and abstinence, Peptides, 11 (1990) 969-972.
24. Marco, N., Stinus, L., Allard, M., LeMoal, M. and Simonnet, G., Neuropeptide FLFQPQRFamide receptors within the ventral mesencephalon and dopaminergic terminal areas: localization and functional antiopioid involvement, Neuroscience, 64 (1995) 1035-1044.
25. Miller, K.K. and Lupica, C.R., Morphine-induced excitation of pyramidal neurons is inhibited by cholecystokinin in the CAl region of the rat hippocampal slice, J. Pharmacol. Exp. Ther., 268 (1994) 753-761.
26. Mudge, A.W., Leeman, S.E. and Fischbach, G.D., Enkephalin inhibits release of substance P from sensory neurons in culture and decreases acion potential duration, Proc. Natl. Acad. Sci. USA, 76 (1979) 526-530.
27. Oberling, P., Stinus, L., Le Moal, M. and Simonnet, G., Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat, Peptides, 14 (1993) 919-924.
28. 5-enkephalin on hippocampal pyramidal cells and interneurons, Neuropharmacology, 28 (1989) 1175-1181.
29. Raffa, R.B. and Connelly, C.D., Supraspinal antinociception produced by [d-met2] FMRFamide in mice, Neuropeptide, 22 (1992) 195-203.
30. Rothman, R.B., A review of the role of anti-opioid peptides in morphine tolerance and dependence, Synapse, 12 (1992) 129-138.
31. Rothman, R.B., Brady, L.S., Xu, H. and Long, J.B., Chronic intracerebroventricular infusion of the antiopioid peptide, phe-leu-phe-gln-pro-gln-arg-phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain, Peptides, 14 (1993) 1271-1277.
32. Schroeder, J.E. and McCleskey, E.W., Inhibition of Ca++ currents by a μ-opioid in a defined subset of rat sensory neurons, J. Neurosci., 13 (1993) 867-873.
33. Siggins, G.R. and Zieglgansberger, W., Morphine and opioid peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potential, Proc. Natl. Acad. Sci. USA, 78 (1981) 5235-5239.
34. Valentine, R.J. and Dingledine, R., Pharmacological characterization of opioid effects in the rat hippocampal slice, J. Pharmacol. Exp. Ther., 223 (1982) 502-509.
35. Wang, X.-J., Wang, X.-H. and Han, J.-S., Cholecystokinin octapeptide antagonized opioid analgesia mediated by μ- and κ- but not δ-receptors in the spinal cord of the rat, Brain Res., 523 (1990) 5-10.
36. Wimpey, T.L. and Chavkin, C., Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation, Neuron, 6 (1991) 281-289.
37. Woodruff, G.N. and Hughes, J., Cholecystokinin antagonists, Annu. Rev. Pharmacol. Toxicol., 31 (1991) 469-501.
38. Yang, H.-Y., Fratta, W., Majane, E.A. and Costa, E., Isolation, sequencing, synthesis and pharmacological characterization of two brain neuropeptides that modulate the actions of morphine, Proc. Natl. Acad. Sci. USA, 82 (1985) 7757-7761.
39. Zhu, J., Jhamandas, K. and Yang, H.-Y., Release of neuropeptide FF (FLFQPQRF-NH2) from rat spinal cord, Brain Res., 592 (1992) 326-332.
40. Zieglgansberger, W., French, E.D., Siggins, G.R. and Bloom, F.E., Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons, Science, 205 (1979) 415-417.